A large open access dataset of brain metastasis 3D segmentations on MRI with clinical and imaging information.
Divya RamakrishnanLeon JekelSaahil ChadhaAnastasia JanasHarrison MoyNazanin MalekiMatthew SalaManpreet KaurGabriel Cassinelli PetersenSara MerkajMarc von ReppertUjjwal BaidSpyridon BakasClaudia KirschMelissa DavisKhaled BousabarahWolfgang HollerMingDe LinMalte WesterhoffSanjay AnejaFatima MemonMariam S AboianPublished in: Scientific data (2024)
Resection and whole brain radiotherapy (WBRT) are standard treatments for brain metastases (BM) but are associated with cognitive side effects. Stereotactic radiosurgery (SRS) uses a targeted approach with less side effects than WBRT. SRS requires precise identification and delineation of BM. While artificial intelligence (AI) algorithms have been developed for this, their clinical adoption is limited due to poor model performance in the clinical setting. The limitations of algorithms are often due to the quality of datasets used for training the AI network. The purpose of this study was to create a large, heterogenous, annotated BM dataset for training and validation of AI models. We present a BM dataset of 200 patients with pretreatment T1, T1 post-contrast, T2, and FLAIR MR images. The dataset includes contrast-enhancing and necrotic 3D segmentations on T1 post-contrast and peritumoral edema 3D segmentations on FLAIR. Our dataset contains 975 contrast-enhancing lesions, many of which are sub centimeter, along with clinical and imaging information. We used a streamlined approach to database-building through a PACS-integrated segmentation workflow.
Keyphrases
- artificial intelligence
- deep learning
- machine learning
- brain metastases
- magnetic resonance
- contrast enhanced
- small cell lung cancer
- magnetic resonance imaging
- high resolution
- early stage
- squamous cell carcinoma
- computed tomography
- resting state
- healthcare
- health information
- electronic health record
- radiation induced
- drug delivery
- blood brain barrier
- functional connectivity
- single cell
- rectal cancer